Cipla completes Phase-3 clinical study for generic version of GSK Advair Diskus Medical Dialogues Bureau5 April 2020 9:11 AM GMTMumbai: Cipla Limited has announced the successful completion of the Phase-3 clinical end-point study for fluticasone propionate and salmeterol inhalat...
HUL completes GSK merger, buys Horlicks in Rs 3,045 crores Medical Dialogues Bureau4 April 2020 8:06 AM GMTHorlicks has a volume share of close to 50 per cent in the HFD market
GSK India appoints Mr Sridhar Venkatesh as Managing Director & VP Medical Dialogues Bureau4 March 2020 12:13 PM GMTMumbai: Mr Sridhar Venkatesh has been appointed as Managing Director & VP of GSK India effective 1 April 2020. He succeeds Mr Annaswamy Vaidheesh w...
EMA accepts GSK filing for Trelegy Ellipta use in adults with asthma Medical Dialogues Bureau4 March 2020 4:45 AM GMTonce-daily single inhaler triple therapy available for asthma and COPD if approved
GSK India to sell Vemgal facility Medical Dialogues Bureau8 Feb 2020 4:00 AM GMT As part of this strategic review, GSK India will explore future options for the Vemgal facility including a potential sale of the site, it added. Ne...
GSK, CEPI collaborate to develop vaccine for 2019-nCoV virus Medical Dialogues Bureau4 Feb 2020 4:00 AM GMT Both CEPI and GSK are committed to principles of equitable access and will work together in this collaboration to ensure that this principle governs ...
GSK launches Iodex UltraGel Medical Dialogues Bureau31 Jan 2020 7:53 AM GMTNew Delhi – GSK announced the launch of Iodex UltraGel, a new age clinically proven gel-based body pain solution. Backed by science, the new vari...
Trivitron Healthcare aims over Rs 1000 crore revenue in FY22 Medical Dialogues Bureau21 Jan 2020 4:30 AM GMT 'We are looking at a revenue of over Rs 1,000 crore for the fiscal year 2022. It will be achieved through organic and inorganic growth,' Trivitron He...
